Literature DB >> 579324

Decreased tuftsin concentrations in patients who have undergone splenectomy.

Z Spirer, V Zakuth, S Diamant, W Mondorf, T Stefanescu, Y Stabinsky, M Fridkin.   

Abstract

Serum tuftsin concentrations were measured, using a radioimmunoassay developed in Israel, in normal subjects and in patients who had undergone splenectomy. Concentrations in those who had undergone traumatic and elective splenectomy were much lower. The tuftsin concentration in 38 patients with Hodgkin's disease who had undergone splenectomy during staging laparotomy was not significantly different from the mean concentration in other patients who had had elective splenectomy. In four patients who underwent splenectomy for non-malignant haematological disorders measurements made before and after operation showed that tuftsin concentrations fell significantly in the days after operation. The increased susceptibility to overwhelming infections of patients with Hodgkin's disease and others who have undergone splenectomy may be related to the low tuftsin concentrations. As pre-splenectomy tuftsin concentrations in patients with Hodgkin's disease were normal, the practice of performing staging laparotomy and splenectomy in patients with Hodgkin's disease should perhaps be reconsidered.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 579324      PMCID: PMC1632692          DOI: 10.1136/bmj.2.6102.1574

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Hyposplenism in ulcerative colitis.

Authors:  F P Ryan; R Smart; F E Preston; C D Holdsworth
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

2.  A new phagocytosis-stimulating tetrapeptide hormone, tuftsin, and its role in disease.

Authors:  V A Najjar; A Constantopoulos
Journal:  J Reticuloendothel Soc       Date:  1972-08

3.  Defective phagocytosis due to tuftsin deficiency in splenectomized subjects.

Authors:  A Constantopoulos; V A Najjar; J B Wish; T H Necheles; L L Stolbach
Journal:  Am J Dis Child       Date:  1973-05

4.  Characterization of postsplenectomy bacteremia among patients with and without lymphoma.

Authors:  S S Donaldson; M R Moore; S A Rosenberg; K L Vosti
Journal:  N Engl J Med       Date:  1972-07-13       Impact factor: 91.245

5.  Tuftsin - unimportant or forgotten.

Authors:  S W Mikulski; D D Von Hoff; M Rozencweig; F M Muggia
Journal:  N Engl J Med       Date:  1977-02-24       Impact factor: 91.245

6.  Immunological abnormalities in splenic atrophy.

Authors:  C A Wardrop; J H Dagg; F D Lee; H Singh; J F Dyet; A Moffat
Journal:  Lancet       Date:  1975-07-05       Impact factor: 79.321

7.  "Tuftsin": a natural phagocytosis stimulating peptide.

Authors:  V A Najjar; K Nishioka
Journal:  Nature       Date:  1970-11-14       Impact factor: 49.962

8.  Sepsis and congenital asplenia.

Authors:  J D Waldman; A Rosenthal; A L Smith; S Shurin; A S Nadas
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

9.  Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes.

Authors:  M Fridkin; Y Stabinsky; V Zakuth; Z Spirer
Journal:  Biochim Biophys Acta       Date:  1977-01-24

10.  Reticuloendothelial system phagocytic function in patients with Hodgkin's disease.

Authors:  J N Sheagren; J B Block; S M Wolff
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

View more
  13 in total

1.  The characteristics of purified HL60 tuftsin receptors.

Authors:  N J Bump; V A Najjar; J Reichler
Journal:  Mol Cell Biochem       Date:  1990-01-18       Impact factor: 3.396

2.  Impaired neutrophil function in intestinal lymphangiectasia.

Authors:  R P Bolton; K L Cotter; M S Losowsky
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

3.  Defective activation of neutrophils after splenectomy.

Authors:  P N Foster; R P Bolton; K L Cotter; M S Losowsky
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

Review 4.  Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.

Authors:  M Fridkin; P Gottlieb
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

5.  After splenectomy.

Authors: 
Journal:  Br Med J       Date:  1978-10-14

Review 6.  Use of cephalosporins in the immunologically compromised patient.

Authors:  A C Newland; H Gaya
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome.

Authors:  F Trevisani; E Castelli; F G Foschi; M Parazza; E Loggi; M Bertelli; C Melotti; M Domenicali; G Zoli; M Bernardi
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

8.  [Alterations of humoral and cellular immunity after splenectomy (author's transl)].

Authors:  M Winkelmeyer; K Littmann; O Thraenhart; G Tichy; E K Kuwert; F W Eigler
Journal:  Klin Wochenschr       Date:  1981-05-15

9.  Reticuloendothelial function in coeliac disease and ulcerative colitis.

Authors:  K R Palmer; D C Barber; S B Sherriff; C D Holdsworth
Journal:  Gut       Date:  1983-05       Impact factor: 23.059

Review 10.  The clinical and physiological aspects of tuftsin deficiency syndromes exhibiting defective phagocytosis.

Authors:  V A Najjar
Journal:  Klin Wochenschr       Date:  1979-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.